EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Page 1 of 1
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Jon Moulton Wed Aug 29, 2012 5:07 pm
Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, Veldink JH, Hardiman O, Van Den Bosch L, Gonzalez-Perez P, Van Damme P, Brown RH Jr, van den Berg LH, Robberecht W. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012 Aug 26. doi: 10.1038/nm.2901. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
» Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
» Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis
» Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis
» Deleterious mutations in the essential mRNA metabolism factor, hGle1, in Amyotrophic Lateral Sclerosis
» Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
» Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis
» Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis
» Deleterious mutations in the essential mRNA metabolism factor, hGle1, in Amyotrophic Lateral Sclerosis
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum